CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, J. E.
Right arrow Articles by Polakis, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, J. E.
Right arrow Articles by Polakis, P.

Cell Growth & Differentiation, Vol 8, Issue 7 801-809, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage

JE Thomas, M Smith, JL Tonkinson, B Rubinfeld and P Polakis
Department of Cancer Research, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA. Thomas_James_E@lilly.com

BRCA1, the familial breast cancer susceptibility gene product, is a 220-kDA phosphorylated protein. BRCA1 immunoprecipitated from MCF7 cells blocked in G1-S phase or progressing through S-phase of the cell cycle migrated more slowly through SDS polyacrylamide gels than BRCA1 from cells maintained in serum-supplemented media, serum-free media for 24 h, or delayed in G2-M phase by treatment with colchicine. Restoration of BRCA1 to the faster-migrating form, which occurred on release of cells from the G1-S-phase block, was prevented by the phosphatase inhibitor okadaic acid. Phosphatase treatment of immunoprecipitated BRCA1 resulted in the conversion of the slower-migrating form to the faster-migrating form. Although these results suggested that BRCA1 was preferentially hyperphosphorylated near the G1-S-phase boundary of the cell cycle, exposure of cells to DNA-damaging agents including UV light or treatment with hydrogen peroxide (H2O2) also promoted BRCA1 hyperphosphorylation. These same stimuli also eliminated the punctate nuclear staining pattern normally observed for BRCA1 in control cells. These results indicate that BRCA1 undergoes cyclic hyperphosphorylation during the cell cycle; however, this modification, as well as changes in BRCA1 nuclear staining, also occurs in response to DNA damage.


This article has been cited by other articles:


Home page
J Biol ChemHome page
G. Jiang, I. Plo, T. Wang, M. Rahman, J. H. Cho, E. Yang, B. S. Lopez, and F. Xia
BRCA1-Ku80 Protein Interaction Enhances End-joining Fidelity of Chromosomal Double-strand Breaks in the G1 Phase of the Cell Cycle
J. Biol. Chem., March 29, 2013; 288(13): 8966 - 8976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. C. Korrapati, J. Chilakapati, E. A. Lock, J. R. Latendresse, A. Warbritton, and H. M. Mehendale
Preplaced cell division: a critical mechanism of autoprotection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death in mice
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F439 - F455.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E M Rosen, S Fan, and C Isaacs
BRCA1 in hormonal carcinogenesis: basic and clinical research
Endocr. Relat. Cancer, September 1, 2005; 12(3): 533 - 548.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer
Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells
J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. D. Choudhury, H. Xu, and R. Baer
Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression
J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Miralem and H. K. Avraham
Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus
Mol. Cell. Biol., January 15, 2003; 23(2): 579 - 593.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Liu, D. M. Virshup, R. L. White, and L.-C. Hsu
Regulation of BRCA1 Phosphorylation by Interaction with Protein Phosphatase 1{alpha}
Cancer Res., November 15, 2002; 62(22): 6357 - 6361.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. J. Huber, T. W. Yang, C. J. Sarkisian, S. R. Master, C.-X. Deng, and L. A. Chodosh
Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci
Mol. Cell. Biol., June 15, 2001; 21(12): 4005 - 4015.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ruffner, C. A. P. Joazeiro, D. Hemmati, T. Hunter, and I. M. Verma
Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
PNAS, April 24, 2001; 98(9): 5134 - 5139.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Arizti, L. Fang, I. Park, Y. Yin, E. Solomon, T. Ouchi, S. A. Aaronson, and S. W. Lee
Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression
Mol. Cell. Biol., October 15, 2000; 20(20): 7450 - 7459.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Chen
Ataxia Telangiectasia-related Protein Is Involved in the Phosphorylation of BRCA1 following Deoxyribonucleic Acid Damage
Cancer Res., September 1, 2000; 60(18): 5037 - 5039.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
X. Yu and R. Baer
Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor
J. Biol. Chem., June 16, 2000; 275(24): 18541 - 18549.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Thompson, P-L. Chen, R. A. King, S. S. Rich, W. S. Oetting, C. Armstrong, A. R. Folsom, and T. A. Sellers
BRCA1 Susceptibility Markers and Postmenopausal Breast Cancer: The Iowa Women's Health Study
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 507 - 511.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
F. Hayes, C. Cayanan, D. Barilla, and A. N. A. Monteiro
Functional Assay for BRCA1: Mutagenesis of the COOH-Terminal Region Reveals Critical Residues for Transcription Activation
Cancer Res., May 1, 2000; 60(9): 2411 - 2418.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. M. Pao, R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma
CBP/p300 interact with and function as transcriptional coactivators of BRCA1
PNAS, February 1, 2000; 97(3): 1020 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
J.-S. LEE, K. COLLINS, A. BROWN, C.-H. LEE, and J.H. CHUNG
The Function of BRCA1 in DNA Damage Response
Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 547 - 552.
[Abstract] [PDF]


Home page
J Biol ChemHome page
S. Altiok, D. Batt, N. Altiok, A. Papautsky, J. Downward, T. M. Roberts, and H. Avraham
Heregulin Induces Phosphorylation of BRCA1 through Phosphatidylinositol 3-Kinase/AKT in Breast Cancer Cells
J. Biol. Chem., November 5, 1999; 274(45): 32274 - 32278.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T.-C. Suen and P. E. Goss
Transcription of BRCA1 Is Dependent on the Formation of a Specific Protein-DNA Complex on the Minimal BRCA1 Bi-directional Promoter
J. Biol. Chem., October 29, 1999; 274(44): 31297 - 31304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma
BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site
Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Thakur and C. M. Croce
Positive Regulation of the BRCA1 Promoter
J. Biol. Chem., March 26, 1999; 274(13): 8837 - 8843.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L.-C. Hsu and R. L. White
BRCA1 is associated with the centrosome during mitosis
PNAS, October 27, 1998; 95(22): 12983 - 12988.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
X. Yu, L. C. Wu, A. M. Bowcock, A. Aronheim, and R. Baer
The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression
J. Biol. Chem., September 25, 1998; 273(39): 25388 - 25392.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. C. Gowen, A. V. Avrutskaya, A. M. Latour, B. H. Koller, and S. A. Leadon
BRCA1 Required for Transcription-Coupled Repair of Oxidative DNA Damage
Science, August 14, 1998; 281(5379): 1009 - 1012.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
X. Yu and R. Baer
Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor
J. Biol. Chem., June 16, 2000; 275(24): 18541 - 18549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.